HIGHLIGHTS
- who: Ying Qing from the (UNIVERSITY) have published the paper: Targeted metabolomics reveals aberrant profiles of serum bile acids in patients with schizophrenia, in the Journal: (JOURNAL)
- what: The study demonstrates that BA pool size and composition are significantly different in patients with SZ when compared to HCs, and suggests that BAs may be involved in the pathophysiology of SZ via the gut microbiota-FXR signaling pathway. The score plots of the models showed a separation between SZ and HC groups in both discovery and validation sets (Fig 1A, B). This study provides new evidence . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.